Knyazev; Pjotr

Patent Applications and Registrations

Patent applications and USPTO patent grants for Knyazev; Pjotr.The latest application filed is for "diagnosis and prevention of cancer cell invasion".

Company Profile

0.7.8

Knyazev; Pjotr - Stockdorf N/A DE
Knyazev; Pjotr - Gauting DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinoline derivatives as AXL kinase inhibitors Grant 9,206,130 - Ullrich , et al. December 8, 2	2015-12-08
Diagnosis And Prevention Of Cancer Cell Invasion App 20130084300 - ULLRICH; Axel ; et al.	2013-04-04
Diagnosis and prevention of cancer cell invasion Grant 8,277,802 - Ullrich , et al. October 2, 2	2012-10-02
Method of diagnosing an RTK-hyperfunction induced disorder Grant 8,043,806 - Ullrich , et al. October 25, 2	2011-10-25
Quinoline Derivatives As Axl Kinase Inhibitors App 20110092503 - Ullrich; Axel ; et al.	2011-04-21
Her3 As A Determinant For The Prognosis Of Melanoma App 20110033482 - Ullrich; Axel ; et al.	2011-02-10
Use Of Inhibitors For The Treatment Of Rtk-hyperfunction-induced Disorders, Particularly Cancer App 20100184686 - Ullrich; Axel ; et al.	2010-07-22
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer Grant 7,678,372 - Ullrich , et al. March 16, 2	2010-03-16
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer Grant 7,297,774 - Ullrich , et al. November 20, 2	2007-11-20
Diagnosis and prevention of cancer cell invasion App 20050186571 - Ullrich, Axel ; et al.	2005-08-25
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer App 20040235776 - Ullrich, Axel ; et al.	2004-11-25
Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer Grant 6,770,742 - Ullrich , et al. August 3, 2	2004-08-03
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer App 20040067885 - Ullrich, Axel ; et al.	2004-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.